Despite delays in cannabis legalization efforts in the U.S., Tilray (NASDAQ: TLRY) still has its eyes on that prize. The company’s CEO, Irwin Simon, told investors on the company’s earnings call that if the U.S. legalized medical marijuana, it would “represent an additional $250-million opportunity for Tilray.” He based that figure …
Arizona marijuana sales continue slide through November
The Arizona marijuana market hit its lowest point of 2024 in November, with a grand total of $89.6 million in sales, according to state data. That includes $73.1 million in recreational sales and another $16.5 million in medical sales, both respective lows for the 2024 calendar year. That’s also down …
Colorado cannabis tax revenue dips in November despite higher sales
Colorado’s cannabis tax collection fell in November, despite sales ticking up in October. Sales rose to $113.3 million in October, as the state’s maturing market continues to see growing competition from other states and falling prices. That increase in monthly sales was up less than 1% from September’s $112.4 million, …
High Tide jumps into Germany with acquisition
High Tide Inc. (Nasdaq: HITI) (TSXV: HITI) is jumping into the German medical marijuana program by buying 51% of Purecan GmbH, for approximately €4.8 Million and will have a future option to acquire the remaining interest in the company. The deal is expected to close in a matter of weeks. …